Access Pharmaceuticals, Inc. recently hired public relations firm Edelman to increase public awareness of the company’s new oral mucositis treatment MuGard. Oral mucositis, a disease that targets membranes of the mouth and gastrointestinal tract, is potentially debilitating.
Houston, Texas-based Access Pharmaceuticals is a biopharmaceutical company that focuses on developing and marketing a series of proprietary products for the care of cancer patients. The company’s product line includes MuGard, ProLindac (for treating ovarian cancer) and Thirabine (a new nucleoside). Access also produces the CobaCyte and CobOral drug delivery systems. Edelman is a PR firm with offices in 53 cities and 3,700 employees worldwide, with numerous Agency of the Year and Best Workplace awards.
Jeffrey Davis, CEO of Access, said, “Edelman has a great track record in conveying the value of company pipelines to a broad range of media outlets. We believe we are at the right time in the Access story and the commercialization of MuGard to expand our reach in within trade and consumer publications. As we continue to execute on our strategy of growing the MuGard brand, capitalizing on Edelman’s strategic skills, creativity and global reach to communicate the benefit and control it provides cancer patients will be key in achieving our MuGard education and communications objectives.”
Bruce Hayes, general manager of Health for Edelman said, “We are pleased that Access has made the decision to join our portfolio of health clients. An emerging player in the cancer supportive care industry, Access is helping patients who suffer from oral mucositis. We are confident that our public engagement strategies will assist in building the MuGard brand and raising Access’ visibility among its key audiences.”
About QualityStocks:
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment